Bioray Biotech Co., Ltd (TPEX:7561)

Bioray Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	178.21	97.02	139.07	126.31	145.91
Cash & Short-Term Investments	178.21	97.02	139.07	126.31	145.91
Cash Growth	83.68%	-30.23%	10.10%	-13.43%	-31.49%
Accounts Receivable	54.63	52.62	47.16	39.75	26.97
Other Receivables	0.1	2.1	1.75	3.9	2.79
Receivables	54.74	54.72	48.92	43.65	29.76
Inventory	46.27	55.95	52.89	45.56	48.38
Prepaid Expenses	16.17	7.87	9.29	2.61	4.04
Other Current Assets	10	0.09	0.1	0.1	0.1
Total Current Assets	305.39	215.65	250.26	218.23	228.18
Property, Plant & Equipment	50.45	310.82	331.8	229.59	223.85
Goodwill	-	-	1.3	1.3	1.3
Other Intangible Assets	0.86	1.42	1.95	1.8	1.82
Long-Term Deferred Tax Assets	4.71	4.99	2.55	2.6	3.16
Other Long-Term Assets	182.23	9.76	10.77	12.67	17.5
Total Assets	543.63	542.65	598.63	466.18	475.8
Accounts Payable	4.52	9.49	12.64	11.47	6.68
Accrued Expenses	-	-	-	0.07	0.11
Short-Term Debt	-	-	15	25	27.2
Current Portion of Leases	6.65	4.14	6.57	3.77	5.87
Current Income Taxes Payable	-	0.1	0.68	0.85	-
Current Unearned Revenue	15.57	10.6	13.12	16.1	14.61
Other Current Liabilities	16.98	18.78	19.81	19.97	21.07
Total Current Liabilities	43.73	43.1	67.82	77.22	75.54
Long-Term Debt	35	-	-	-	-
Long-Term Leases	44.13	65.66	79.34	24.66	28.52
Long-Term Deferred Tax Liabilities	0.05	-	-	0	0
Other Long-Term Liabilities	-	-	-	0.37	-
Total Liabilities	122.9	108.75	147.16	102.26	104.05
Common Stock	300.85	300.85	300.85	268.85	267.32
Additional Paid-In Capital	133.51	133.51	133.51	78.45	72.45
Retained Earnings	1.06	0.06	17.64	17.14	30.13
Comprehensive Income & Other	-14.69	-0.53	-0.53	-0.52	-0.52
Total Common Equity	420.73	433.9	451.47	363.92	369.37
Minority Interest	-	-	-	-	2.38
Shareholders' Equity	420.73	433.9	451.47	363.92	371.75
Total Liabilities & Equity	543.63	542.65	598.63	466.18	475.8
Total Debt	85.78	69.79	100.91	53.43	61.58
Net Cash (Debt)	92.43	27.23	38.16	72.88	84.32
Net Cash Growth	239.42%	-28.63%	-47.65%	-13.57%	-43.63%
Net Cash Per Share	2.77	0.91	1.36	2.72	3.15
Filing Date Shares Outstanding	36.73	30.09	29.15	26.89	26.73
Total Common Shares Outstanding	36.73	30.09	29.15	26.89	26.73
Working Capital	261.66	172.55	182.44	141.01	152.65
Book Value Per Share	11.45	14.42	15.49	13.54	13.82
Tangible Book Value	419.87	432.47	448.22	360.82	366.25
Tangible Book Value Per Share	11.43	14.38	15.37	13.42	13.70
Buildings	-	281.8	237.36	226.86	215.95
Machinery	-	97.23	78.47	68.75	52.51
Construction In Progress	-	-	39.92	-	0.36
Leasehold Improvements	-	2.84	2.84	2.84	2.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.